Literature DB >> 2027074

IgG antibody response of localized juvenile periodontitis patients to the 29 kilodalton outer membrane protein of Actinobacillus actinomycetemcomitans.

M E Wilson1.   

Abstract

Levels of serum IgG antibody to the 29 kilodalton outer membrane protein of A. actinomycetemcomitans Y4 in sera of periodontally healthy subjects and localized juvenile periodontitis patients were determined using an enzyme-linked immunosorbent assay (ELISA). The 29 kDa protein was isolated by solubilization of an octylglucoside-NaCl insoluble fraction by incubation at ambient temperature in 20 mM sodium phosphate, pH 7.5, containing 1% sodium dodecyl sulfate. The isolated protein migrated on SDS-polyacrylamide gels with an apparent molecular mass of 29 kDa following incubation in sample buffer at ambient temperature. However, the protein migrated with an apparent molecular mass of 34 kDa following incubation in sample buffer at 100 degrees C for 10 minutes. Geometric mean IgG antibody titers to the 29 kDa protein were significantly higher in sera from LJP subjects than in sera obtained from periodontally healthy subjects. Twenty-two of 35 LJP sera (63%) had antibody titers greater than 2 standard deviations from the mean titer of the periodontally healthy group. Among LJP subjects, elevated antibody titers to the 29 kDa protein were found primarily in subjects greater than or equal to 18 years of age, with the highest titers seen in patients 18 to 21 years of age. The results of this study indicate that the humoral response of LJP subjects to A. actinomycetemcomitans includes the production of IgG antibodies which recognize the major outer membrane proteins of this organism.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2027074     DOI: 10.1902/jop.1991.62.3.211

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  17 in total

1.  The heat-modifiable outer membrane protein of Actinobacillus actinomycetemcomitans: relationship to OmpA proteins.

Authors:  M E Wilson
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

2.  Molecular cloning of the Pasteurella haemolytica pomA gene and identification of bovine antibodies against PomA surface domains.

Authors:  H Zeng; K Pandher; G L Murphy
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

3.  Specific antibody reactivity against a 110-kilodalton Actinobacillus actinomycetemcomitans protein in subjects with periodontitis.

Authors:  T F Fleming; I Selmair; H Schmidt; H Karch
Journal:  Clin Diagn Lab Immunol       Date:  1996-11

Review 4.  Periodontal disease immunology: 'double indemnity' in protecting the host.

Authors:  Jeffrey L Ebersole; Dolphus R Dawson; Lorri A Morford; Rebecca Peyyala; Craig S Miller; Octavio A Gonzaléz
Journal:  Periodontol 2000       Date:  2013-06       Impact factor: 7.589

5.  Identification of an immunoglobulin Fc receptor of Actinobacillus actinomycetemcomitans.

Authors:  K P Mintz; P M Fives-Taylor
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

6.  Characteristics of adherence of Actinobacillus actinomycetemcomitans to epithelial cells.

Authors:  D H Meyer; P M Fives-Taylor
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

7.  Immunoglobulin G subclass response of localized juvenile periodontitis patients to Actinobacillus actinomycetemcomitans Y4 lipopolysaccharide.

Authors:  M E Wilson; R G Hamilton
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

8.  Opsonization of Actinobacillus actinomycetemcomitans by immunoglobulin G antibodies to the O polysaccharide of lipopolysaccharide.

Authors:  M E Wilson; P M Bronson
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

9.  Influence of anti-Actinobacillus actinomycetemcomitans Y4 (serotype b) lipopolysaccharide on severity of generalized early-onset periodontitis.

Authors:  J V Califano; J C Gunsolley; K Nakashima; H A Schenkein; M E Wilson; J G Tew
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

10.  Subinhibitory concentrations of cefpodoxime alter membrane protein expression of Actinobacillus actinomycetemcomitans and enhance its susceptibility to killing by neutrophils.

Authors:  P J Baker; W F Busby; M E Wilson
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.